Michael Dabrowski, Pelago Bioscience

CETSA allows physiological relevant quantification of target engagement, which is prerequisite for achieving the intended efficacy. Therefore CETSA has during the last 8 years been applied from early target validation to analysis of clinical samples.

In his talk Michael will explore examples of applications and also discuss future perspectives in enabling drug discovery using the CETSA method.